• PDF: Delivered by email usually within 4 to 8 UK business hours.

Eye Care in Belgium

  • Publication Date:August 2013
  • Publisher:Euromonitor
  • Product Type: Report
  • Pages:33
  • ISBN:490175

Eye Care in Belgium

Sales of eye care products are usually dynamic, but were dampened by two negative factors in 2012. First, the category was in indirect competition with increasingly successful eye care supplements such as Préservision 3 from Bausch & Lomb and Nutrof Omega by Théa Pharma. Then, due to the climatic conditions in the spring and summer, allergy eye care often experiences irregular sales, with frequent peaks and troughs. Again in 2012, cases of conjunctivitis were rare during the wet spring and...

Euromonitor International's Eye Care in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.

Product coverage: Allergy Eye Care, Standard Eye Care.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Eye Care market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market's major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International
August 2013


Competitive Landscape
Category Data
Table 1 Sales of Eye Care by Category: Value 2007-2012
Table 2 Sales of Eye Care by Category: % Value Growth 2007-2012
Table 3 Standard Eye Care by Format: % Value Breakdown 2008-2012
Table 4 Standard Eye Care by Positioning: % Value Breakdown 2008-2012
Table 5 Eye Care Company Shares by Value 2008-2012
Table 6 Eye Care Brand Shares by Value 2009-2012
Table 7 Forecast Sales of Eye Care by Category: Value 2012-2017
Table 8 Forecast Sales of Eye Care by Category: % Value Growth 2012-2017
Executive Summary
2012 Is Not A Good Year for Consumer Health
More Repressive Juridical Context Than Deregulation
Multinationals Are the Most Affected
Distribution Remains Under the Control of Chemists/pharmacies, Despite Some Changes
Bleak Prospects Overall
Key Trends and Developments
the Outlook Is Clouding Over for Consumer Health
Health and Wellness Called To Order
Local Authorities and Experts Do Not Help Matters
Urgent Need for Calm
Local Environment Leaves More Limited Room for Manoeuvre for Multinationals
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 10 Life Expectancy at Birth 2007-2012
Market Data
Table 11 Sales of Consumer Health by Category: Value 2007-2012
Table 12 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 13 Consumer Health Company Shares 2008-2012
Table 14 Consumer Health Brand Shares 2009-2012
Table 15 Penetration of Private Label by Category 2007-2012
Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 18 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Summary 1 OTC: Switches 2010-2012
Summary 2 Research Sources

+44 20 8816 8548

Ask a question about Eye Care in Belgium

Enter the characters you see in the picture below